Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Avastin bevacizumab: Phase II data

In a Phase II trial in 120 patients, median PFS was 4.8 months in the

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE